Detailed answers about CANCER CURE TRUST, including incorporation, status, business activity, and accounts information.
When was CANCER CURE TRUST founded?
CANCER CURE TRUST was officially incorporated on 6 July 2018 and is registered under company number 11452033. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CANCER CURE TRUST?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of CANCER CURE TRUST?
CANCER CURE TRUST's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CANCER CURE TRUST do?
CANCER CURE TRUST operates in the following sectors: 62090 - Other information technology service activities, 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is CANCER CURE TRUST's registered address?
The registered office address of CANCER CURE TRUST is 5 DANESWOOD, MARCHWIEL, WREXHAM, WALES, LL13 0RG. This is the official address filed with Companies House for legal and statutory correspondence.
Is CANCER CURE TRUST financially stable?
The most recent accounts for CANCER CURE TRUST were made up to 31 March 2025, filed as DORMANT. Next accounts are due by 31 December 2026.
Does CANCER CURE TRUST have any charges or mortgages?
CANCER CURE TRUST has 2 registered charges, of which 2 are outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.